SC
DGX icon

Steven Cohen’s Quest Diagnostics DGX Stock Holding History

Steven Cohen’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,300
Closed -$158K – 2296
2023
Q3 		$158K Hold
1,300
– – ﹤0.01% 1821
2023
Q2 		$183K Buy
+1,300
New +$179K ﹤0.01% 1452

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Steven Cohen's DGX Position: Q2 2026 in Review

Steven Cohen opened a new position in Quest Diagnostics (DGX) in Q2 2026: 23,380 shares worth $4.96M. The stake represents 0.01% of the portfolio and ranks #1766 among its holdings. This is a return to the name: Steven Cohen previously reported a position in DGX as recently as Q4 2025.

Steven Cohen first reported a position in DGX in Q2 2014 and has held it in 14 quarters since. The position peaked at $137M in Q2 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Steven Cohen held 23,380 shares of Quest Diagnostics worth $4.96M as of Q2 2026.
  • Quest Diagnostics was a new Steven Cohen position in Q2 2026.
  • Quest Diagnostics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1766 holding.
  • Steven Cohen first reported a position in Quest Diagnostics in Q2 2014 and has held it in 14 quarters since.
  • Steven Cohen's Quest Diagnostics position peaked at $137M in Q2 2023.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.